Cargando…
Commonalities for comorbidity: Overlapping features of the endocannabinoid system in depression and epilepsy
A wealth of clinical and pre-clinical data supports a bidirectional comorbidity between depression and epilepsy. This suggests commonalities in underlying mechanisms that may serve as targets for more effective treatment strategies. Unfortunately, many patients with this comorbidity are highly refra...
Autor principal: | Epps, S. Alisha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626804/ https://www.ncbi.nlm.nih.gov/pubmed/36339877 http://dx.doi.org/10.3389/fpsyt.2022.1041460 |
Ejemplares similares
-
Endocannabinoid System Components as Potential Biomarkers in Psychiatry
por: Navarrete, Francisco, et al.
Publicado: (2020) -
Editorial: Psychiatric comorbidities in patients with epilepsy: diagnosis and treatment
por: Oddo, Silvia, et al.
Publicado: (2023) -
The Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder
por: Chye, Yann, et al.
Publicado: (2019) -
Endocannabinoid System Unlocks the Puzzle of Autism Treatment via Microglia
por: Su, Tangfeng, et al.
Publicado: (2021) -
Editorial: The Endocannabinoid System: Filling the Translational Gap Between Neuroscience and Psychiatry
por: De Gregorio, Danilo, et al.
Publicado: (2021)